Please login to the form below
ERS Genomics
This page shows the latest ERS Genomics news and features for those working in and with pharma, biotech and healthcare.
Latest Intelligence
-
Deal Watch May 2016
disease late last year, Bayer announced another gene editing pact this month with ERS Genomics. ... Financial details were not disclosed. Like CRISPR Therapeutics ERS Genomics holds rights to the foundational CRISPR-Cas9 patent portfolio from Dr.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Eric Rhodes becomes CEO of ERS Genomics
Succeeds the company’s founder Shaun Foy in the role. ERS Genomics, an Irish biotechnology firm, has appointed Eric Rhodes as its new chief executive officer. ... Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
